Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 33 34 35 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
GAPVAC project–EU (govt): grant, 201307– FP7 grant €6m 2013-07-01
GSK–Immunocore: ImmTAC technology, 201307– collab research + license agreement with GSK 2013-07-01
Hybrigenics–Dualsystems Biotech: yeast two-hybrid services, 201307 acquisition €na of Y2H activities of Dualsystems by Hybrigenics Services 2013-07-01
Protagen–Zukunftsfonds Heilbronn: investment, 201307 acquisition of Protagen Protein Services GmbH by Zukunftsfonds Heilbronn 2013-07-01
Barilla–Mérieux: mass spectrometry, 201306 collab developm MRM MS technique to determine contaminants in bakery products Mérieux NutriSciences 2013-06-28
Fresenius–Neopharm (IL): investment, 201306 acquisition €na of Fresenius Biotech GmbH by Neopharm Group 2013-06-28
Mérieux–Thermo Fisher: mass spectrometer, 201306 supply existent LC-HRMS Exactive Orbitrap used to develop MRM MS technique by Mérieux NutriSciences 2013-06-28
BioVersys–SEVERAL: investment, 201306 financing round Series A from existing + new investors 2013-06-27
RJ Lee Group–Ionicon: mass spectrometer, 201306– distribution excl in US of Ionicon trace gas analysis products incl service + support 2013-06-27
Roche–Immunocore: ImmTAC technology, 201306– collab research + license $10–20m upfront + $300m+ milestones + royalties per target progr w Genentech 2013-06-27
Biotest–SEVERAL: investment, 201306 capital increase €76m 1.46m new preference shares €52/share 2013-06-26
Celgene–MorphoSys: antibody cancer drug, 201306–201503 collab strat alliance up to €628m incl €70.8m upfront acqu ww rights to MOR202 TERMINATED 3/15 2013-06-26
Middle Peak Medical–SEVERAL: investment, 201306 financing round Series A $8.5m co-led by Wellington Partners + Seventure Partners + incl HTGF 2013-06-26
MorphoSys–Celgene: investment, 201306 acquisition of €46.2m new MorphoSys shares as part of strategic alliance w regard to MOR202 2013-06-26
Analytik Jena–Endress+Hauser: investment, 201306 acquisition additional 10.69% from Jens Adomat raising shareholding of E+H in AJ to over 20% 2013-06-25
Bayer–Seattle Genetics: ADC technology, 201306– collab ww rights for Bayer to use ADC techn w antibodies for several oncology targets 2013-06-25
WBM Health Science–Medicyte: cell technology, 201306– collab promotion of Medicyte products + services in India by WBM 2013-06-25
Artes Biotechnology–Midas Pharma: business development services, 201306– collab Midas supports to find potential partners + markets for Artes 2013-06-24
Dualsystems Biotech–ETH Zürich: drug discovery technology, 201306– license to TriCEPS-based LRC technology 2013-06-24
Evocatal–SEVERAL: investment, 201306 financing round Series B €3.5m from Lanxess + NRW.BANK et al 2013-06-24
Vasopharm–SEVERAL: investment, 201306 financing round Series F €5m led by HeidelbergCapital + Entrepreneurs Fund 2013-06-24
ImaBiotech–Bruker Corp: mass spectrometer, 201206 supply existent most recent instrument addition is 7 Tesla SolariX from Bruker Daltonics 2013-06-20
ImaBiotech–Genfit: drug discovery, 201206– collab long-term incl sharing of tech platforms + mutual drug discovery services 2013-06-20
Boehringer–Karolinska Institutet: therapeutic antibody, 201306– option to acquire fully human MAb program for athersclerosis fr Athera Biotechnologies 2013-06-19
Henkel–c-LEcta: detergent enzymes, 201306– collab development 2013-06-19
Unilabs–Natera: Panorama prenatal test, 201306– distribution of Panorama test in Scandinavia by Unilabs 2013-06-13
Unilabs–Natera: Panorama prenatal test, 201306– distribution of Panorama test in Switzerland by Unilabs 2013-06-13
Valneva–SEVERAL: investment, 201306–201307 financing round €40m capital increase 15m new shares incl FSI + Groupe Grimaud 2013-06-13
Xradia–Carl Zeiss: investment, 201306–201307 acquisition of Xradia Inc renamed Carl Zeiss X-ray Microscopy Inc 2013-06-13
Bruker Corp–ImaBiotech: mass spectrometry software, 201306– distribution of Quantinetix s/w for quantitative MALDI imaging by Bruker 2013-06-10
Harvard Univ–Thermo Fisher: mass spectrometer, 201306 supply Orbitrap Fusion system used by Steven Gygi at Harvard Medical School 2013-06-10
JnJ–Genedata: bioinformatics, 201306 supply existent use of Genedata Expressionist for Mass Spectrometry by Janssen R&D 2013-06-10
PerkinElmer–CTC Analytics: sample preparation technology, 201306– collab supply AxION Sample Manager sample prep + analysis solution by CTC 2013-06-10
Cell Signaling Technology–Trinean: spectrophotometer, 201306– BIOKÉ to distribute Trinean products in Germany 2013-06-07
Cell Signaling Technology–Trinean: spectrophotometer, 201306– BIOKÉ to distribute Trinean products in the Netherlands 2013-06-07
Deloitte Touche Tohmatsu–Thomson Reuters: investment, 201306 acquisition of substantially all assets of Deloitte Recap LLC by Thomson Reuters 2013-06-07
Diagnoplex–Debiopharm: investment, 201306 financing round totalling CHF1.3m incl lead investor Debiopharm 2013-06-07
Diagnoplex–SEVERAL: investment, 201306 financing round CHF1.3m led by Debiopharm 2013-06-07
EBD Group–Informa: investment, 201306 acquisition £30m in cash of EBD Group by Informa 2013-06-07
EBS Technologies–High-Tech Gründerfonds: investment, 201306 financing round Series B €3m incl co-investor HTGF 2013-06-07
EBS Technologies–SEVERAL: investment, 201306 financing round Series B €3m lead investor Earlybird plus HTGF + Brandenburg Capital 2013-06-07
Bruker Corp–CovalX: mass spectrometry, 201306– collab ww support to combine CovalX high-mass systems with Bruker autoflex + ultraflex instruments 2013-06-06
M-SPEC (DE)–NONE: investment, 201306–201401 bankruptcy Local Court Mainz 280 IN 123/13 2013-06-06
Thermo Fisher–SEVERAL: investment, 201306 common stock offering $2.53b 25.7m+3.85m shares at $85.5/share 2013-06-05
Bruker Corp–3M: MALDI Imaging, 201306– license excl to technique for performing MS analysis on FFPE tissue 2013-06-04
Bruker Corp–3M: MALDI Imaging, 201609– license expansion excl to technique for performing MS analysis on FFPE tissue for pathology 2013-06-04
Univ Hamburg–Bruker Corp: mass spectrometer, 201306 supply existent MALDI Molecular Imager used by Prof H Schlüter in FFPE prostate cancer study UKE 2013-06-04
Exquiron Biotech–Enamine: chemical compound library, 201306– collab multi-year supply of diverse screening compound library by Enamine 2013-06-03
GSK–MorphoSys: MOR103, 201306– global license for €22.5m upfront + €423m milestones + double-digit royalties 2013-06-03
Entelechon–Eurofins: investment, 201306 acquisition by Eurofins MWG Operon 2013-06-01
GOBI project–Genedata: bioinformatics, 201306–201605 Genedata is project partner supplying Genedata Selector for data analysis 2013-06-01
GOBI project–Germany (govt): grant, 201306–201605 BMBF funding for general optimisation of biogas processes 2013-06-01
NOFUN project–EU (govt): grant, 201306– FP7 funding €6.1m 2013-06-01
PS Biotech–High-Tech Gründerfonds: investment, 201306 seed investment by HTGF 2013-06-01
Merck (DE)–BeiGene: cancer drug, 201305– collab co-developm + commercialisation of BRAF inhibitor BeiGene-283 by Merck Serono 2013-05-31
Okairos–GSK: investment, 201305 acquisition for €250m in cash 2013-05-29
Medigene–Sinphar Pharmaceutical: investment, 201305 acquisition €2.4m with 2.4m new shares €1/share by SynCore resulting in 6% shareholding 2013-05-27
Sinphar Pharmaceutical–Medigene: EndoTAG-1, 201305– collab expansion co-developm + commercialisation globally by SynCore Biotechnology 2013-05-27
SIP Biotech Development–Qiagen: companion diagnostics, 201305– collab establishment of joint venture Qiagen (Suzhou) Translational Medicine Center 2013-05-24
Debiopharm–Cenix BioScience: biomarker discovery, 201305– collab Cenix to use HCS to identify predctive biomarkers for cancer drug candidates 2013-05-23
SuppreMol–SEVERAL: investment, 201305 financing round Series D 2nd closing €9.5m 2013-05-21
AOP Orphan–Élan: investment, 201305– acquisition €533.5m with €157.7m cash + €87.8m ordinary shares + €270m milestones ANNOUNCED 2013-05-20
Effector Therapeutics–Abingworth: investment, 201305 financing round Series A totalling $45m incl investor Abingworth 2013-05-20
Effector Therapeutics–Novartis: investment, 201305 financing round Series A totalling $45m incl investor Novartis Venture Funds 2013-05-20
Effector Therapeutics–SEVERAL: investment, 201305 financing round Series A $45m incl USVP + Abingworth + Novartis VF + SR One + Astellas Venture 2013-05-20
NewBridge Pharmaceuticals–Élan: investment, 201305 acquisition 48% share for $40m with option to acquire remaining stake for $244m by 2015 2013-05-20
Evotec–Harvard Univ: drug discovery, 201305– collab identification + optimisation of small molecule antibacterials 2013-05-16
Steigerwald Arzneimittelwerk–Bayer: investment, 201305–201307 acquisition €na 2013-05-16
BASF–Direvo Industrial Biotechnology: feed enzymes, 201305 collab extension joint developm protease for pig + poultry feed w BASF Animal Nutrition 2013-05-15
Dolosys–High-Tech Gründerfonds: investment, 201305 seed financing from HTGF + m2f Investment Ltd 2013-05-15
Dolosys–m2f Investment: investment, 201305 seed financing from HTGF + m2f Investment Ltd 2013-05-15
Dolosys–SEVERAL: investment, 201305 seed financing from HTGF + m2f Investment Ltd 2013-05-15
Merck (DE)–Quintiles: clinical research services, 201305– supply 5y Quintiles sole-primary provider global clinical developm services for Merck Serono 2013-05-15
TeFuProt project–Germany (govt): grant, 201305– funding €4.5m of total project cost €9m 6y by BMBF via »Innovationsinitiative Industr Biotechnologie« 2013-05-15
Bruker Corp–SCiLS GmbH: SCiLS Lab s/w, 201305– collab excl partnership for use of SCiLS Lab s/w w Bruker MALDI Imaging solutions 2013-05-14
Univ Jena–Bruker Corp: mass spectrometer, 201305 supply Prof v Eggeling existent user of Bruker MALDI Imaging equipment 2013-05-14
Univ Jena–SCiLS GmbH: SCiLS Lab s/w, 201305 supply existent Prof v Eggeling is beta tester of SCiLS Lab s/w using Bruker MALDI Imaging equipment 2013-05-14
Greenovation–Biomeva: alfa-galactosidase, 201305– collab developm + manufacturing + supply agreem using BryoMaster moss expression system 2013-05-06
SIRS-Lab–Analytik Jena: investment, 201305 acquisition €na of all assets of bankrupt SIRS-Lab GmbH 2013-05-06
Structural Genomics Consortium–Boehringer: epigenetics, 201305– collab Boehringer joins SGC as new member 2013-05-06
Roche–Evotec: drug discovery services, 201305–201604 collab extension for 3 years discovery small molecule drugs for Genentech 2013-05-01
Evotec–Harvard Univ: drug discovery, 201304– collab target validation for epigenetics-guided cancer drug discovery Dana-Farber Cancer Institute 2013-04-30
AbClon–Pepperprint: peptide microarrays, 201302– distribution with marketing + sales rights for Pepperprint products in Korea 2013-04-29
Boehringer–Oxford BioTherapeutics: drug target discovery, 201304– collab €na to discover cancer antibody targets using OGAP platform 2013-04-29
Conceptus–Bayer: investment, 201304–201306 acquisition merger cash tender offer $1.1b=€852m $31/share Bayer HealthCare LLC 2013-04-29
Ingenuity Systems–Qiagen: investment, 201304 acquisition for $105m in cash 2013-04-29
Becton Dickinson–Bruker Corp: mass spectrometer, 201304– collab expansion sell + provide techn support for MALDI Biotyper w BD Phoenix + EpiCenter 2013-04-27
Jado–NONE: investment, 201301–201304 bankruptcy Jado Technologies GmbH Local Court Dresden 533 IN 2725/12 2013-04-25
Genticel–LCF Rothschild: investment, 201304 financing round €18.2m incl returning co-investor EdRIP 2013-04-24
Genticel–SEVERAL: investment, 201304 financing round €18.2m led by Wellington Partners incl all current institutional investors 2013-04-24
Genticel–Wellington Partners: investment, 201304 financing round €18.2m incl €4m from lead investor Wellington Partners 2013-04-24
GME Medical Engineering–High-Tech Gründerfonds: investment, 201304 financing round totalling €1m inkl returning investor HTGF 2013-04-24
GME Medical Engineering–SEVERAL: investment, 201304 financing round €1m from BayBG + HTGF + Bayern Kapital + private investors incl Dieter Manstein 2013-04-24
Miltenyi Biotec–Omnicom: public relations, 201304 service existent by Fleishman-Hillard 2013-04-24
Activaero–MC Services: public relations, 201304 service existent for Activaero GmbH 2013-04-23
Analytik Ltd–GeSiM: biochip spotting technology, 201304 distribution existent Analytik Ltd is excl distributor for Nano-Plotter in UK + IRL 2013-04-23
Aotec Instrumentos Cientificos–Danaher: investment, 201304 acquisition 100% by Leica Microsystems + Leica Biosystems of former Brazilian distributor 2013-04-23
Owl Biomedical–Miltenyi Biotec: investment, 201304 acquisition €na 2013-04-23
Personal MedSystems–BPCE: investment, 201304 Series A investment €2.5m by Seventure Partners 2013-04-23
Biocrea–MC Services: public relations, 201304 service existent for Biocrea GmbH 2013-04-22
next pagenext page 1 2 3 ... 33 34 35 ... 54 55 56  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top